Quinoline‐based heterocyclic hydrazones: Design, synthesis, anti‐plasmodial assessment, and mechanistic insights
Chemical Biology & Drug Design · 2023-04 · 101 (4) · 829-836
DOI: 10.1111/cbdd.14185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2022-12. Verfasst von Bharvi Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Guru Nanak Dev University, Amritsar, India. Hauptthemen laut MEDLINE: Antimalarials, Quinolines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
A library of quinoline‐based hydrazones bearing 1 H ‐1,2,3‐triazole core was designed, synthesized, and evaluated for their antiplasmodial activity against the drug‐resistant Plasmodium falciparum W2 strain. The inclusion of pyrazine‐2‐carboxylic acid with a flexible propyl spacer afforded the most active scaffold with an IC 50 value of 0.26 μM. Mechanistically, the compound inhibited heme to hemozoin formation, as demonstrated by UV–vis and mass spectral studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Guru Nanak Dev University, Amritsar, India.
- Department of Medicine, University of California, San Francisco, California, USA.
ORCID-Profile: Vipan Kumar
Zitieren
APA
Sharma, B., Chowdhary, S., Legac, J., Rosenthal, P. J., & Kumar, V. (2023). Quinoline‐based heterocyclic hydrazones: Design, synthesis, anti‐plasmodial assessment, and mechanistic insights. Chemical Biology & Drug Design, 101(4), 829-836. https://doi.org/10.1111/cbdd.14185
Vancouver
Sharma B, Chowdhary S, Legac J, Rosenthal PJ, Kumar V. Quinoline‐based heterocyclic hydrazones: Design, synthesis, anti‐plasmodial assessment, and mechanistic insights. Chemical Biology & Drug Design. 2023;101(4):829-836. doi:10.1111/cbdd.14185
BibTeX
@article{Sharma2023,
author = {Sharma, Bharvi and Chowdhary, Shefali and Legac, Jenny and Rosenthal, Philip J and Kumar, Vipan},
title = {Quinoline‐based heterocyclic hydrazones: Design, synthesis, anti‐plasmodial assessment, and mechanistic insights},
journal = {Chemical Biology & Drug Design},
year = {2023},
volume = {101},
number = {4},
pages = {829--836},
doi = {10.1111/cbdd.14185}
}
EUVIMED